Biomarkers in Multiple Myeloma (MM): Overview

Video

Jonathan Kaufman, MD, provides an overview of multiple myeloma (MM) and reviews current biomarkers and molecular pathways commonly seen in MM.

Related Videos
Video 4 - "Challenges in Adopting Targeted Therapies for BRAF Alterations"
Video 3 - "BRAF V600E Mutant Ganglioglioma"
Michael Leung, PharmD, an expert on colorectal cancer
A panel of 4 experts on colorectal cancer
Video 4 - "The Evolving Treatment Landscape with CDK4/6 Inhibitors in Early HR+/HER2- Breast Cancer"
Richard Finn, MD, and David James Pinato, MD, MRCP, PhD, experts on hepatocellular carcinoma
Richard Finn, MD, and David James Pinato, MD, MRCP, PhD, experts on hepatocellular carcinoma
Video 2 - "Targeting RET Fusion in Brain Tumor"
Video 6 - "Patient Case 2: A 62-Year-Old Woman with Metastatic Rectal Cancer"
Video 5 - "Adverse Events Associated With TAS-102 Plus Bevacizumab in CRC"
Related Content
Erika P. Hamilton, MD

Antibody-Drug Conjugates Expand HER2+ Breast Cancer Treatment Options

December 5th 2022
Article
Peter Gibbs, MBBS, MD, FRACP, a medical oncologist at St Vincent’s Private Hospitals and a professor at the University of Melbourne in Australia

MRD Detection Emerges as a Catalyst for Advances in Colon Cancer

December 5th 2022
Article
DetermaIO Assay Helps Inform Benefit With Single-Agent Immunotherapy in Advanced NSCLC

DetermaIO Assay Helps Inform Benefit With Single-Agent Immunotherapy in Advanced NSCLC

November 22nd 2022
Article
Shaji Kumar, MD

Biomarker-Directed Therapy in Multiple Myeloma Signals the Future of the Field

September 1st 2022
Article
Treating Patients with Gastric Cancer

Treating Patients with Gastric Cancer

August 25th 2022
Article
Multidisciplinary Management of Patients with Basal Cell Carcinoma

Multidisciplinary Management of Patients with Basal Cell Carcinoma

August 24th 2022
Article